Krause Kevin Michael

Sociétés où Krause Kevin Michael a négocié

• AN2 Therapeutics, Inc.13 tx · $236.4K · Mar 29, 2024

Historique de performance de Krause Kevin Michael

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de Krause Kevin Michael

Co-initiés de Krause Kevin Michael

• Adjuvant Capital GP, L.P.AN2 Therapeutics, Inc.
• Adjuvant Capital Management, LLCAN2 Therapeutics, Inc.
• Adjuvant Global Health Technology Fund DE, L.P.AN2 Therapeutics, Inc.
• Adjuvant Global Health Technology Fund, L.P.AN2 Therapeutics, Inc.
• Aziz KabeerAN2 Therapeutics, Inc.
• Chanda SanjayAN2 Therapeutics, Inc.
• Day LucyAN2 Therapeutics, Inc.
• Easom EricAN2 Therapeutics, Inc.
• Eckburg PaulAN2 Therapeutics, Inc.
• Eizen Joshua MAN2 Therapeutics, Inc.
• FitzPatrick Margaret MAN2 Therapeutics, Inc.
• Kolchinsky PeterAN2 Therapeutics, Inc.
• Leonard Braden MichaelAN2 Therapeutics, Inc.
• Marks Gilbert LynnAN2 Therapeutics, Inc.
• Martin Patricia A.AN2 Therapeutics, Inc.
• Nazak Michael AdrianAN2 Therapeutics, Inc.
• Prior Stephen DavidAN2 Therapeutics, Inc.
• RA Capital Biotech Fund LPAN2 Therapeutics, Inc.
• RA Capital Nexus Fund II, L.P.AN2 Therapeutics, Inc.
• Readnour Robin ShaneAN2 Therapeutics, Inc.
• Shah Rajeev M.AN2 Therapeutics, Inc.
• Spigelman Melvin KAN2 Therapeutics, Inc.
• Trenor Cameron C. IIIAN2 Therapeutics, Inc.
• Williams Sarah JoanneAN2 Therapeutics, Inc.
• Wong StephanieAN2 Therapeutics, Inc.
• Zakrzewski Joseph SAN2 Therapeutics, Inc.